Ordinary Rebalance | Global Anti Virus Health Index (Price Return) (EUR) | Effective Date 18th March 2024
In the ordinary rebalance, the following composition will be implemented effective open 18.03.2024:
| ABBOTT LABORATORIES |
| ABBVIE INC |
| ASTRAZENECA PLC |
| BAYER AG |
| BRISTOL-MYERS SQUIBB CO |
| ELI LILLY & CO |
| GILEAD SCIENCES INC |
| GSK PLC |
| INCYTE CORP |
| JOHNSON & JOHNSON |
| LABORATORY CRP OF AMER HLDGS |
| MERCK & CO. INC. |
| MODERNA INC |
| NOVARTIS AG |
| PFIZER INC |
| REGENERON PHARMACEUTICALS |
| ROCHE HOLDING AG |
| SANOFI SA |
| THERMO FISHER SCIENTIFIC INC |
| VAXCYTE INC |